Clinical Trials Update: Jan. 25, 2007
Non-Hodgkin's Lymphoma Breast Cancer Contraception
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This is an open-label, randomized study for people with relapsed, follicular B-cell lymphoma. Volunteers at least 18 who have histologically confirmed follicular B-cell lymphoma, have a B-cell population that is CD-20 positive, have received prior therapy for the condition, and do not have CNS lymphoma, chronic lymphocytic leukemia, or small lymphocytic lymphoma may be eligible.
The research sites are located across the United States.
This study will evaluate the effectiveness and safety of ZK-Epo in women with breast cancer that has spread to other parts of the body Women 18 and older who have metastatic breast cancer with a measurable tumor, and have progressive disease following previous chemotherapy may be eligible. Participants may have had no more than three prior regimens of chemotherapy, and cannot be pregnant or breastfeeding.
The research sites are located across the United States and Canada.
This study will evaluate an investigational medication to control blood sugar. Qualified participants must not be taking other medication to control blood sugar levels. Study-related care and study medication will be provided at no cost, and compensation is available for time and travel.
The research site is in West Palm Beach, Fla.
Copyright 2007 Thomson CenterWatch. All rights reserved.